Physician profile
Christopher Juels
NPI 1831501824
$207,589.13
in general payments reported to CMS, 2019-2025
36 companies · $41K in 2025
The $41K reported for 2025 was more than what 99% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,206 · 2020: $7,169 · 2021: $18K · 2022: $35K · 2023: $67K · 2024: $36K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $70K · Consulting Fee: $66K · Travel and Lodging: $4,904 · Food and Beverage: $3,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $69,832.40 |
| Consulting Fee | $65,873.95 |
| Travel and Lodging | $4,903.88 |
| Food and Beverage | $3,251.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trilliant Surgical LLC. | $126,590.26 | 2020-2025 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, Arsenal Sinus Support Plate, Arsenal Ankle |
| Medshape, INC. | $44,306.52 | 2021-2025 | Dynanail Helix, Washer, 15 Mm, Dynanail, Dynanail Mini |
| Anika Therapeutics, INC. | $14,611.79 | 2022-2024 | Glenojet, Tactoset, Integrity |
| Flower Orthopedics Coporation | $6,789.60 | 2025 | |
| Arthrex, INC. | $4,996.05 | 2021-2025 | |
| Stryker Corporation | $2,296.19 | 2019-2025 | Augment Injectable, Prophecy, Infinity Adaptis |
| Relja Innovations INC | $1,500.00 | 2022 | |
| Orthofix Medical, INC. | $1,463.71 | 2019-2023 | Physio-Stim |
| Smoky Mountain Surgical LLC | $1,032.28 | 2025 | |
| Smith+Nephew, INC. | $890.78 | 2019-2025 | Grafix, Healicoil, Stravix Pl |
| Ortho Solutions INC | $522.70 | 2025 | |
| Alpha Orthopedic Systems | $510.70 | 2021-2022 | |
| Encore Medical, Lp | $454.25 | 2021-2022 | |
| Paragon 28, INC. | $247.44 | 2023 | Portfolio |
| Aroa Biosurgery Incorporated | $169.03 | 2022-2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $150.71 | 2019 | |
| Organogenesis INC. | $131.24 | 2022-2025 | Simplimax, Via Matrix, Cygnus Dual |
| Goode Surgical INC | $120.75 | 2019 | |
| X-Spine Systems, INC. | $113.93 | 2019 | |
| Great Lakes Orthopedics | $110.03 | 2019 | |
| Medline Industries Lp | $103.89 | 2019-2021 | |
| Pacira Therapeutics, INC. | $84.98 | 2019-2020 | |
| Nextremity Solutions INC. | $48.65 | 2020 | |
| Arthrosurface Incorporated | $48.19 | 2019 | |
| Horizon Therapeutics Plc | $41.35 | 2019-2020 | |
| Ossur Americas, INC. | $38.47 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $38.46 | 2022-2025 | Zilretta |
| Nevro Corp. | $34.10 | 2022-2023 | Senza |
| Innovation Technologies INC | $24.72 | 2025 | Irrisept |
| Trevena, INC. | $21.03 | 2021 | |
| Abbvie INC. | $19.30 | 2022 | |
| Kerecis Limited | $18.79 | 2022 | |
| Abbott Laboratories | $17.98 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $16.23 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.71 | 2023 | |
| Heraeus Medical, LLC. | $10.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$55,787.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Juels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.